Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udit Singhal

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Journal of Urology|February 7, 2025
Reply by AuthorsJeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, et al.
Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.
Nature Communications|May 21, 2024
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasisUdit Singhal, Srinivas Nallandhighal, Jeffrey J Tosoian, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.
The Journal of Urology|April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRIJeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Urology|February 7, 2025
Reply by AuthorsJeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, et al.
Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.
Nature Communications|May 21, 2024
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasisUdit Singhal, Srinivas Nallandhighal, Jeffrey J Tosoian, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Urology|December 15, 2021
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical NeedJeffrey J Tosoian, Udit Singhal, Matthew S Davenport, et al.
Nature Communications|September 27, 2016
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progressionYashar S Niknafs, Sumin Han, Teng Ma, et al.
The Journal of Urology|April 28, 2026
Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRIJeffrey J Tosoian, Jacob I Meyers, Bradley Moore, et al.
Pageof 5